US advances first government-funded trials of psychedelic drug ibogaine
US health officials are moving forward with the first government-funded clinical trials of the psychedelic drug ibogaine, aiming to treat opioid addiction and post-traumatic stress disorder.
US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, the FDA said on Monday, while also seeking public feedback on safety rules for the studies. The initiative follows…